Z. Paryzek et al. / Tetrahedron Letters 53 (2012) 6212–6215
6215
4. Moser, B. R. J. Nat. Prod. 2008, 71, 487–491.
5. Kuhl, H.; Taubert, H. D. Steroids 1974, 24, 613–626.
6. Templeton, J. F.; Majgier-Baranowska, H.; Marat, K. Steroids 2000, 65, 219–223.
7. DellaGreca, M.; Iesce, M. R.; Previtera, L.; Temussi, F.; Zarrelli, A. J. Org. Chem.
2002, 67, 9011–9015.
matic rings were observed and their interplanar separation of ap-
prox. 3.8 Å was calculated. Similar values have been observed for
p–p
stack arrangements.38 For other dimers, the energy differences
between the syn/anti conformers were lower, by 1.1 and 1.6 kcal/
mol for 7 and 8, respectively.
ˇ
´
ˇ
8. Harmatha, J.; Budešínsky, M.; Vokáac, K. Steroids 2002, 67, 127–135.
9. Davis, A. P. Molecules 2007, 12, 2106–2122.
The dimers synthesized are potential substrates for the prepara-
tion of macrocyclic compounds with predicted cavities. An inter-
esting approach to the synthesis of a new cholaphane was
demonstrated by cyclization of the dimeric bis-carbamate 10.
Selective hydrolysis of 10 (KOH, THF/H2O 4:1) afforded the dimeric
diacid 12. Activation of the carboxyl groups in 12 by the formation
of the mixed anhydride via reaction with ethyl chloroformate (1,4-
dioxane, N-methylmorpholine) followed by treatment with p-
phenylenediamine resulted in the formation of two macrocyclic
compounds: dimer 15 and tetramer 16. The macrocyclization
was fairly effective affording 15 and 16 in isolated yields of 35%
and 19%, respectively (Scheme 3).
In summary, we have developed an efficient procedure for the
preparation of the head-to-head bile acid dimers bearing a bis-car-
bamate, bis-carbonate, or bis-monothiocarbonate moieties in the
spacer group from the readily available 3-chlorocarbonyl deriva-
tives of bile acid esters. Macrocyclization of the dimer 10 afforded
highly functionalized dimeric and tetrameric cholaphanes, 15 and
16, respectively. These acyclic and macrocyclic dimers may find
applications in molecular recognition, supramolecular chemistry,
and in pharmacology.
10. Tamminen, J.; Kolehmainen, E. Molecules 2001, 6, 21–46.
11. McKenna, J. M.; Thornthwaite, D. W. J. Chem. Soc., Chem. Commun. 1977, 809–
811.
12. Virtanen, E.; Tamminen, J.; Haapala, M.; Mänttäri, P.; Kauppinen, R.;
Kolehmainen, E. Magn. Reson. Chem. 2003, 41, 567–576.
13. Salunke, D. B.; Hazra, B. G.; Pore, V. S.; Bhat, M. K.; Nahar, P. B.; Deshpande, M.
V. J. Med. Chem. 2004, 47, 1591–1594.
14. Salunke, D. B.; Hazra, B. G.; Pore, V. S. Arkivoc 2003, ix, 115–125.
15. Łotowski, Z.; Guzman´ ski, D. Monatsh. Chem. 2006, 137, 117–124.
16. Gouin, S.; Zhu, X. X. Steroids 1996, 61, 664–669.
17. Pandey, P. S.; Singh, R. B. Tetrahedron Lett. 1997, 38, 5045–5046.
18. Pandey, P. S.; Rai, R.; Singh, R. B. J. Chem. Soc., Perkin Trans. 1 2002, 918–923.
19. Tamminen, J.; Lappalainen, K.; Torkkel, T.; Seppälä, R. Synthesis 1996, 1082–
1084.
20. Haapala, M.; Kolehmainen, E.; Tamminen, J.; Kauppinen, R.; Linnanto, J.;
Virtanen, E.; Suontamo, R.; Vainiotalo, P. Mater. Sci. Eng., C 2001, 18, 21–23.
21. Tamminen, J.; Kolehmainen, E.; Haapala, M.; Linnanto, J. Synthesis 2000, 1464–
1468.
22. Aher, N. G.; Pore, V. S.; Patil, S. P. Tetrahedron 2007, 63, 12927–12934.
23. Aher, N. G.; Pore, V. S. Synlett 2005, 2155–2158.
24. Zhang, Z.; Ju, Y.; Zhao, Y. Chem. Lett. 2007, 36, 1450–1451.
25. Vatmurge, N. S.; Hazra, B. G.; Pore, V. S.; Shirazi, F.; Deshpande, M. V.;
Kadreppa, S.; Chattopadhyay, S.; Gonnade, R. G. Org. Biomol. Chem. 2008, 6,
3823–3830.
26. Pospieszny, T.; Małecka, I.; Paryzek, Z. Tetrahedron Lett. 2012, 53, 301–305.
27. Dallstream, C.; Dias, J. R. Org. Prep. Proced. Int. 2006, 38, 337–340.
28. Lukashev, N. V.; Kazantsev, A. V.; Averin, A. D.; Donez, P. A.; Baranov, M. S.;
Sievänen, E.; Kolehmainen, E. Synthesis 2009, 4175–4182.
29. Yoshii, M.; Yamamura, M.; Satake, A.; Kobuke, Y. Org. Biol. Chem. 2004, 2, 2619–
2623.
Acknowledgment
30. Matzner, M.; Kurkjy, R. P.; Cotter, R. J. Chem. Rev. 1964, 64, 645–687.
31. Schadendorff, E.; Verdino, A. Monatsh. Chem. 1935, 65, 338–347.
32. Verdino, A.; Schadendorff, E. Monatsh. Chem. 1935, 65, 169–175.
33. Janout, V.; Lanier, M.; Regen, S. L. J. Am. Chem. Soc. 1997, 119, 640–647.
34. Sokolova, T. V.; Maslov, M. A.; Serebrennikova, G. A. Russ. J. Bioorg. Chem. 2004,
30, 477–481.
This investigation was supported by the Ministry of Science and
Higher Education (Project No. N N204 166836).
Supplementary data
35. Paryzek, Z.; Piasecka, M.; Joachimiak, R.; Luks, E.; Radecka-Paryzek, W. J. Rare
Earths 2010, 28, 56–60.
Supplementary data associated with this article can be found, in
36. See Supplementary data.
37. Typical procedure for the preparation of dimers: To a solution of methyl 3
a-
chlorocarbonyloxy-7 ,12 -diacetoxy-5b-cholan-24-oate (569 mg, 1 mmol) in
a
a
THF (10 mL) were added 1,3-diaminobenzene (54.1 mg, 0.5 mmol) and DMAP
(122 mg, 1 mmol) and the mixture was stirred at room temperature until all
the substrates had reacted (2 h). Addition of H2O followed by extraction of the
product with toluene/Et2O gave the crude product which was
chromatographed on silica gel column to give dimer 10 (528 mg, 90%) as a
white solid.36
References and notes
1. Wallimann, P.; Marti, T.; Fürer, A.; Diederich, F. Chem. Rev. 1997, 97, 1567–
1608.
2. Li, Y.; Dias, J. R. Chem. Rev. 1997, 97, 283–304.
3. Nahar, L.; Sarker, S. D.; Turner, A. B. Curr. Med. Chem. 2007, 14, 1349–1370.
38. (a) Hunter, C. A.; Sanders, J. K. M. J. Am. Chem. Soc. 1990, 112, 5525–5534; (b)
Bloom, J. W. G.; Wheeler, S. E. Angew. Chem. 2011, 123, 7993–7995.